171 related articles for article (PubMed ID: 37586167)
21. Human induced pluripotent stem cell (iPSC) line (HEBHMUi014-A) derived from a patient with Alzheimer's disease.
Zhang M; Yu M; Guo R; Zhang Y; Zhang X; Sun J; Zhang J; Wang X; Ma J
Stem Cell Res; 2023 Jun; 69():103116. PubMed ID: 37178573
[TBL] [Abstract][Full Text] [Related]
22. Generation of an erythroid progenitor-derived iPSC line, VRISGi002-A, from a healthy 27-year-old Vietnamese donor under a feeder-free system.
Nhung Nguyen TH; Trinh Tran TT; Luong TH; Nguyen XH
Stem Cell Res; 2022 Jul; 62():102824. PubMed ID: 35679757
[TBL] [Abstract][Full Text] [Related]
23. Generation of Parkinson's disease patient-derived human induced pluripotent stem cells line (PNUSCRi001-A) carrying a N227S mutation in GBA gene.
Lee N; Moon HJ; Park SH; Moon JY; Park KK; Kim JH; Lee JH
Stem Cell Res; 2022 Dec; 65():102959. PubMed ID: 36332465
[TBL] [Abstract][Full Text] [Related]
24. Generation of a human induced pluripotent stem cell line (OGIi001) from peripheral blood mononuclear cells of a healthy male donor.
Zhang H; Daheron L; Cerna-Chavez R; Place EM; Huckfeldt RM; Pierce EA; Garita-Hernandez M
Stem Cell Res; 2024 Feb; 74():103280. PubMed ID: 38134577
[TBL] [Abstract][Full Text] [Related]
25. Establishment of an induced pluripotent stem cell line (SDCHi001-A) from a healthy Chinese child donor.
Wang L; Zeng Q; Wang S; Wu D; Wang J; Zhang H; Lv X
Stem Cell Res; 2024 Feb; 74():103278. PubMed ID: 38118205
[TBL] [Abstract][Full Text] [Related]
26. Establishment of SIAISi021-A, an induced pluripotent stem cell (iPSC) line from a 71-year-old Chinese Han male with Alzheimer's Disease (AD) having two copies of APOE4/4 allele.
Ding Y; Chen H; Zhao J; Wang Y; Deng Y
Stem Cell Res; 2022 Aug; 63():102866. PubMed ID: 35843023
[TBL] [Abstract][Full Text] [Related]
27. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.
Liu S; Niu S; Li Y; Xiong H; Li Y; Jian L; Zhang L
Stem Cell Res; 2020 Oct; 48():101966. PubMed ID: 32911326
[TBL] [Abstract][Full Text] [Related]
28. Induced pluripotent stem cell line ICGi036-A generated by reprogramming peripheral blood mononuclear cells from a patient with familial hypercholesterolemia caused due to compound heterozygous p.Ser177Leu/p.Cys352Arg mutations in LDLR.
Zakharova IS; Shevchenko AI; Tmoyan NA; Elisaphenko EA; Zubkova ES; Sleptcov AA; Nazarenko MS; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM
Stem Cell Res; 2022 Mar; 59():102653. PubMed ID: 34999421
[TBL] [Abstract][Full Text] [Related]
29. Generation of human-induced pluripotent stem cell line from PBMC of healthy donor using integration-free Sendai virus technology.
Sarkar J; Dhepe S; Shivalkar A; Kuhikar R; More S; Konala VBR; Bhanushali P; Khanna A
Stem Cell Res; 2024 Jun; 77():103402. PubMed ID: 38547666
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a human induced pluripotent stem cell line (TAUi008-A) derived from a multiple sclerosis patient.
Lotila J; Hyvärinen T; Skottman H; Airas L; Narkilahti S; Hagman S
Stem Cell Res; 2022 Aug; 63():102865. PubMed ID: 35843021
[TBL] [Abstract][Full Text] [Related]
31. Efficient generation of induced pluripotent stem cell lines from peripheral blood mononuclear cells.
Gao Y; Cheng Y; Wen J; Xiao D; Xu J; Cai C; Hu J
Stem Cell Res; 2023 Jun; 69():103088. PubMed ID: 37099933
[TBL] [Abstract][Full Text] [Related]
32. Generation of human induced pluripotent stem cells (EURACi001-A, EURACi002-A, EURACi003-A) from peripheral blood mononuclear cells of three patients carrying mutations in the CAV3 gene.
Meraviglia V; Benzoni P; Landi S; Murano C; Langione M; Motta BM; Baratto S; Silipigni R; Di Segni M; Pramstaller PP; DiFrancesco D; Gazzerro E; Barbuti A; Rossini A
Stem Cell Res; 2018 Mar; 27():25-29. PubMed ID: 29304398
[TBL] [Abstract][Full Text] [Related]
33. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations.
Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q
Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557
[TBL] [Abstract][Full Text] [Related]
34. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7.
Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY
Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186
[TBL] [Abstract][Full Text] [Related]
35. Generation of an induced pluripotent stem cell line (GWCMCi005-A) from a patient with Lennox-Gastaut syndrome carrying TANC2 Gln1441Ter mutation.
Tian Y; Shi Z; Liao Y; Cai J; Li W; Li X; Chen WX
Stem Cell Res; 2022 Apr; 60():102667. PubMed ID: 35066241
[TBL] [Abstract][Full Text] [Related]
36. Generation of two familial hypercholesterolemia patient-specific induced pluripotent stem cell lines harboring heterozygous mutations in the LDLR gene.
Gao J; Li J; Xu L; Yan CD; Knowles JW; Wu JC
Stem Cell Res; 2024 Jun; 78():103463. PubMed ID: 38852422
[TBL] [Abstract][Full Text] [Related]
37. Generation and characterization of a human iPSC line SANi005-A containing the gray platelet associated heterozygous mutation p.Q287* in GFI1B.
Hansen M; Varga E; Wüst T; Mellink C; van der Kevie-Kersemaekers AM; Marneth AE; von Lindern M; van der Reijden B; van den Akker E
Stem Cell Res; 2017 Dec; 25():34-37. PubMed ID: 29055225
[TBL] [Abstract][Full Text] [Related]
38. Derivation of an induced pluripotent stem cell line (FDCHi014-A) from PBMCs of a seven-year-old patient with a truncating NOVA2 variant (c.625del).
Yin T; Qian Y; Zhang X; Liao Y; Wu B; Wang S; Wang H
Stem Cell Res; 2024 Apr; 76():103369. PubMed ID: 38430735
[TBL] [Abstract][Full Text] [Related]
39. iPSC-Derived Endothelial Cells Reveal LDLR Dysfunction and Dysregulated Gene Expression Profiles in Familial Hypercholesterolemia.
Zakharova IS; Shevchenko AI; Arssan MA; Sleptcov AA; Nazarenko MS; Zarubin AA; Zheltysheva NV; Shevchenko VA; Tmoyan NA; Saaya SB; Ezhov MV; Kukharchuk VV; Parfyonova YV; Zakian SM
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255763
[TBL] [Abstract][Full Text] [Related]
40. Generation and characterization of human induced pluripotent stem cell line METUi001-A from a 25-year-old male patient with relapsing-remitting multiple sclerosis.
Begentas OC; Koc D; Yurtogullari S; Temel M; Akcali KC; Demirkaya S; Kiris E
Stem Cell Res; 2021 May; 53():102370. PubMed ID: 34087999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
